The Chicago health-tech company spent a decade trying to build the whole medical record. Then it kept the least glamorous piece - the dictionary - and turned that narrow wedge into a clinical-data business valued at more than $1.5 billion.
Hospitals do not need another dazzling demo if yesterday’s lab result is still trapped in the wrong system. Rhapsody has spent decades turning that unglamorous mess into a business - and now it is teaching an AI agent to mind the pipes.